The UCSF Helen Diller Family Comprehensive Cancer Center hosted an afternoon event on the Mission Bay campus on May 12 to showcase recent progress and current research directions in the fight against cancer. Plenary session speakers included UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, Frank McCormick, ...

The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF. Provenge is a newly-approved, life-extending prostate cancer treatment for men with advanced disease. Medical centers that helped to carry out ...

Former Intel Corp. chief executive Andy Grove has pledged $1.5 million to two University of California campuses -- San Francisco and Berkeley - to jointly launch the first program of its kind aimed at accelerating the translation of cutting-edge research into advances in patient care.

Targeted therapies tailored to the unique biology of brain tumors may offer renewed hope to children diagnosed with the number one cause of cancer death, according to faculty at UCSF Children's Hospital. An estimated 4,030 new cases of brain and central nervous system tumors in ...

For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) - the most common form of non-invasive breast cancer - are at risk of developing more invasive tumors in later years. As a result of the ...

UCSF researchers have found a novel association between human papillomavirus (HPV) infection and increased HIV acquisition in women. The study team also identified specific types of HPV associated with HIV infection, suggesting a biological basis for HIV transmission to women. "The finding is not conclusive ...